{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:09:30Z","timestamp":1773983370447,"version":"3.50.1"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cognit."],"abstract":"<jats:p>Parkinson's disease (PD) is a complex disorder that is influenced by multiple genetic risk factors. There is a significant heterogeneity in PD presentation, both pathologically and clinically. Some of the most common and important symptoms affecting the patient are cognitive impairment and dementia. However, the genetic and biological basis underlying the differences in cognitive profiles, including the development of dementia in PD, is not yet well understood. Understanding the role of genes in cognitive outcomes is crucial for effective patient counseling and treatment. Research on familial PD has discovered more than 20 genes that can cause the disease. The identified genes responsible for familial cases of PD are <jats:italic>LRRK2, PARK7, PINK1, PRKN<\/jats:italic>, or <jats:italic>SNCA<\/jats:italic> gene, although there may be other genes that also contribute. Additionally, some of these genes may also play a role in cases that were previously thought to be sporadic. Currently, numerous well-described genes increase the risk of cognitive decline in PD, each with varying levels of penetrance. The aim of this review is to identify the relevant genetic factors that contribute to differences in cognition. We discuss the genes that may affect cognition and the challenges in establishing a clear genetic diagnostic and prognostic assessment. This article aims to demonstrate the complexity of the genetic background of cognition in PD and to present the different types of genotype changes that can impact cognition through various neurobiological mechanisms.<\/jats:p>","DOI":"10.3389\/fcogn.2024.1379896","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T04:46:48Z","timestamp":1721623608000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic background of cognitive decline in Parkinson's disease"],"prefix":"10.3389","volume":"3","author":[{"given":"Antonela","family":"Blazekovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Gotovac Jercic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Devedija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran","family":"Borovecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.parkreldis.2014.09.033","article-title":"Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease","volume":"21","author":"Alcalay","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/13803390903521018","article-title":"Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease","volume":"32","author":"Alcalay","year":"2010","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1517\/13543784.2015.1075002","article-title":"Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease","volume":"24","author":"Anand","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jns.2017.08.3259","article-title":"PITX3 genotype and risk of dementia in Parkinson's disease: a population-based study","volume":"381","author":"B\u00e4ckstr\u00f6m","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.parkreldis.2011.10.009","article-title":"Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease","volume":"18","author":"Ben Sassi","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2013.12.051","article-title":"BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease","volume":"561","author":"Bia\u0142ecka","year":"2014","journal-title":"Neurosci. Lett."},{"key":"B7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/mds.29342","article-title":"Polygenic Parkinson's disease genetic risk score as risk modifier of parkinsonism in Gaucher disease","volume":"38","author":"Blauwendraat","year":"2023","journal-title":"Mov. Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","article-title":"GBA-associated PD presents with nonmotor characteristics","volume":"77","author":"Brockmann","year":"2011","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"136243","DOI":"10.1016\/j.neulet.2021.136243","article-title":"The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: a longitudinal observational study","volume":"764","author":"Chung","year":"2021","journal-title":"Neurosci. Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.parkreldis.2015.10.010","article-title":"Association of type 2 diabetes GWAS loci and the risk of Parkinson's and Alzheimer's diseases","volume":"21","author":"Chung","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neurol.2014.10.003","article-title":"Amyloid beta peptide immunotherapy in Alzheimer disease","volume":"170","author":"Delrieu","year":"2014","journal-title":"Rev. Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.neurobiolaging.2021.04.011","article-title":"Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses","volume":"105","author":"Dilliott","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1002\/mds.23806","article-title":"Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease","volume":"26","author":"Factor","year":"2011","journal-title":"Mov. Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41531-023-00619-5","article-title":"Proxy-analysis of the genetics of cognitive decline in Parkinson's disease through polygenic scores","volume":"10","author":"Faouzi","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.neurobiolaging.2007.08.014","article-title":"The transcription factor PITX3 is associated with sporadic Parkinson's disease","volume":"30","author":"Fuchs","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"B16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ana.20819","article-title":"Interface between tauopathies and synucleinopathies: a tale of two proteins","volume":"59","author":"Galpern","year":"2006","journal-title":"Ann. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12883-022-02897-7","article-title":"The presence and co-incidence of geriatric syndromes in older patients with mild-moderate Lewy body dementia","volume":"22","author":"Gan","year":"2022","journal-title":"BMC Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5334\/tohm.768","article-title":"Cognitive performance as a function of MAPT haplotype: a prospective longitudinal study of an essential tremor cohort","volume":"13","author":"Ghanem","year":"2023","journal-title":"Tremor Other Hyperkinet. Mov."},{"key":"B19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ana.21192","article-title":"Tau and \u03b1-synuclein in susceptibility to, and dementia in, Parkinson's disease","volume":"62","author":"Goris","year":"2007","journal-title":"Ann. Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e14440","DOI":"10.1111\/cns.14440","article-title":"The roles of apolipoprotein E \u03b54 on neuropathology and neuroinflammation in patients with Alzheimer's disease","volume":"30","author":"He","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jocn.2016.10.013","article-title":"Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease","volume":"36","author":"Hong","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2020.03.017","article-title":"Parkinson's disease polygenic risk score is not associated with impulse control disorders: a longitudinal study","volume":"75","author":"Ihle","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/mds.27845","article-title":"Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts","volume":"34","author":"Iwaki","year":"2019","journal-title":"Mov. Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3390\/genes12121975","article-title":"Microarray genotyping identifies new loci associated with dementia in Parkinson's disease","volume":"12","author":"Jo","year":"2021","journal-title":"Genes"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/brain\/awab402","article-title":"Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups","volume":"145","author":"Kaivola","year":"2022","journal-title":"Brain"},{"key":"B26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1601-183X.2007.00315.x","article-title":"Risk and protective haplotypes of the alpha-synuclein gene associated with Parkinson's disease differentially affect cognitive sequence learning","volume":"7","author":"K\u00e9ri","year":"2008","journal-title":"Genes Brain Behav."},{"key":"B27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3233\/JPD-202288","article-title":"Potential Sex-specific effects of apolipoprotein E \u03b54 on cognitive decline in early Parkinson's disease","volume":"11","author":"Kim","year":"2021","journal-title":"JPD"},{"key":"B28","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/jamapsychiatry.2017.2228","article-title":"Association of white matter with core cognitive deficits in patients with schizophrenia","volume":"74","author":"Kochunov","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1212\/NXG.0000000000000492","article-title":"Genetic risk scores and hallucinations in patients with Parkinson disease","volume":"6","author":"Kusters","year":"2020","journal-title":"Neurol Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2217\/imt.13.162","article-title":"Immunotherapy targeting \u03b1-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders","volume":"6","author":"Lindstr\u00f6m","year":"2014","journal-title":"Immunotherapy"},{"key":"B31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.parkreldis.2014.12.027","article-title":"CSF tau and tau\/A\u03b242 predict cognitive decline in Parkinson's disease","volume":"21","author":"Liu","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"B32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ana.24781","article-title":"Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's","volume":"80","author":"Liu","year":"2016","journal-title":"Ann. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41588-021-00847-6","article-title":"Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease","volume":"53","author":"Liu","year":"2021","journal-title":"Nat. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3233\/JAD-220976","article-title":"Age-related association between APOE \u03b54 and cognitive progression in de novo Parkinson's disease","volume":"91","author":"Liu","year":"2023","journal-title":"JAD"},{"key":"B35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.parkreldis.2020.04.002","article-title":"Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations","volume":"76","author":"Mangone","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/gerona\/glab327","article-title":"Novel functional, health, and genetic determinants of cognitive terminal decline: Kuakini Honolulu Heart program\/Honolulu-Asia aging study","volume":"77","author":"Margrett","year":"2022","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci. A"},{"key":"B37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.neurobiolaging.2017.04.009","article-title":"Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease","volume":"56","author":"Mata","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.parkreldis.2016.04.013","article-title":"Apolipoprotein E \u03b54 does not affect cognitive performance in patients with Parkinson's disease","volume":"29","author":"Mengel","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.parkreldis.2014.02.001","article-title":"Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status","volume":"20","author":"Monsell","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"B41","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/mds.24946","article-title":"Genetic influences on cognitive decline in Parkinson's disease","volume":"27","author":"Morley","year":"2012","journal-title":"Mov. Disord."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.neuropsychologia.2006.10.017","article-title":"Cognitive sequence learning in Parkinson's disease and amnestic mild cognitive impairment: dissociation between sequential and non-sequential learning of associations","volume":"45","author":"Nagy","year":"2007","journal-title":"Neuropsychologia"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/mds.27768","article-title":"SNCA Rep1 promoter variability influences cognition in Parkinson's disease","volume":"34","author":"Ng","year":"2019","journal-title":"Mov. Disord."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1093\/brain\/awu201","article-title":"Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study","volume":"137","author":"Nombela","year":"2014","journal-title":"Brain"},{"key":"B45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cortex.2018.03.025","article-title":"APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: a review","volume":"104","author":"O'Donoghue","year":"2018","journal-title":"Cortex"},{"key":"B46","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JPD-150762","article-title":"APOE, MAPT, and COMT and Parkinson's disease susceptibility and cognitive symptom progression","volume":"6","author":"Paul","year":"2016","journal-title":"JPD"},{"key":"B47","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jamaneurol.2017.4206","article-title":"Association of polygenic risk score with cognitive decline and motor progression in Parkinson disease","volume":"75","author":"Paul","year":"2018","journal-title":"JAMA Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.pjnns.2018.04.003","article-title":"The impact of apolipoprotein E alleles on cognitive performance in patients with Parkinson's disease","volume":"52","author":"Pierzchli\u0144ska","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/ene.14115","article-title":"Cognitive and psychiatric symptoms in genetically determined Parkinson's disease: a systematic review","volume":"27","author":"Piredda","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.1038\/s41598-021-84316-4","article-title":"Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson's disease using machine learning","volume":"11","author":"Ramezani","year":"2021","journal-title":"Sci. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neurobiolaging.2016.09.001","article-title":"Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy","volume":"48","author":"Rittman","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/alz.13740","article-title":"Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study","volume":"20","author":"Sakurai","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B53","doi-asserted-by":"publisher","first-page":"112039","DOI":"10.1016\/j.bbr.2019.112039","article-title":"Pattern of cortical thinning associated with the BDNF Val66Met polymorphism in Parkinson's disease","volume":"372","author":"Sampedro","year":"2019","journal-title":"Behav. Brain Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects \u03b1-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/jnnp-2019-321111","article-title":"Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1093\/brain\/awac325","article-title":"Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 loci","volume":"145","author":"Soutar","year":"2022","journal-title":"Brain"},{"key":"B57","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mds.28342","article-title":"Genome-wide association studies of cognitive and motor progression in Parkinson's disease","volume":"36","author":"Tan","year":"2021","journal-title":"Mov. Disord."},{"key":"B58","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3233\/JPD-213029","article-title":"Longitudinal study of SNCA Rep1 polymorphism on executive function in early Parkinson's disease","volume":"12","author":"Tan","year":"2022","journal-title":"JPD"},{"key":"B59","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE \u03f54 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1093\/brain\/awad183","article-title":"Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease","volume":"146","author":"Tunold","year":"","journal-title":"Brain"},{"key":"B61","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/mds.29698","article-title":"Lysosomal polygenic burden drives cognitive decline in Parkinson's disease with low alzheimer risk","volume":"39","author":"Tunold","year":"","journal-title":"Mov. Disord."},{"key":"B62","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3233\/JAD-210365","article-title":"Genetics contributes to concomitant pathology and clinical presentation in dementia with lewy bodies","volume":"83","author":"Van Der Lee","year":"2021","journal-title":"JAD"},{"key":"B63","doi-asserted-by":"publisher","first-page":"959469","DOI":"10.3389\/fimmu.2022.959469","article-title":"The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.neurobiolaging.2014.12.006","article-title":"Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals","volume":"36","author":"Winder-Rhodes","year":"2015","journal-title":"Neurobiol. Aging"}],"container-title":["Frontiers in Cognition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcogn.2024.1379896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T04:46:52Z","timestamp":1721623612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcogn.2024.1379896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":65,"alternative-id":["10.3389\/fcogn.2024.1379896"],"URL":"https:\/\/doi.org\/10.3389\/fcogn.2024.1379896","relation":{},"ISSN":["2813-4532"],"issn-type":[{"value":"2813-4532","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"article-number":"1379896"}}